A Review on the Potential Therapeutic Profile of Carica papaya Leaf Extract in the Management of Dengue Fever - DR. PRADEEP B. E.

Similar documents
International Journal of Pharma and Bio Sciences A STUDY OF CLINCAL PROFILE IN DENGUE CASES ABSTRACT

Caripill: An Advance Treatment for Dengue

Seroprevalence and Recent Trends of Dengue in a Rural Area in South India

MODULE 5. Dengue. Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America

Usa Thisyakorn and Chule Thisyakorn

Papaya Extract to Treat Dengue: A Novel Therapeutic Option?

NASRONUDIN 4/17/2013. DENVs of each type are grouped into several genotypes.

Papaya Extract to Treat Dengue: A Novel Therapeutic Option?

Usa Thisyakorn and Chule Thisyakorn

ISSN X (Print) Original Research Article. DOI: /sjams College, Guwahati-32, Assam, India

A study of NS1 antigen and platelet count for early diagnosis of dengue infection

DENGUE AND BLOOD SAFETY. Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo

Clinical Profile of the Dengue Infection in Children

When infections go viral Zika Virus

Comparison between serological & molecular methods for diagnosis of dengue fever and its correlation with duration of illness

NATURE S RETORT TO THE DENGUE CRISIS

Chapter - 1 INTRODUCTION

Surveillance Protocol Dengue Fever (Breakbone fever, Dengue Hemorrhagic Fever)

1. Dengue An Overview. Dengue Expert Advisory Group

International Journal of Allied Medical Sciences

RESEARCH NOTE IDENTIFICATION OF DENGUE VIRUS IN AEDES MOSQUITOES AND PATIENTS SERA FROM SI SA KET PROVINCE, THAILAND

Severe Dengue Infection in ICU. Shirish Prayag MD, FCCM Pune, India

Objectives. Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions. Case 1. Dengue Introduction 10/15/2018

Detection of NS1 antigen, IgM antibody for the diagnosis of dengue infection in patients with acute febrile illness

ORIGINAL ARTICLE. SEROPREVALENCE OF DENGUE IN TERTIARY CARE CENTRE AT LUCKNOW Shipra Singhal 1, Krati R. Varshney 2, Vineeta Mittal 3, Y. I. Singh 4.

Immunopathogenesis of Dengue Hemorrhagic Fever

Zika Virus Update for Emergency Care Providers

Observation on dengue cases from a virus diagnostic laboratory of a tertiary care hospital in north India

Updated Questions and Answers related to the dengue vaccine Dengvaxia and its use

Exchange Program. Thailand. Mahidol University. Mahidol-Osaka Center for Infectious Diseases (MOCID) Date: 2013/06/05~2013/07/04

Dengue: The next vaccine preventable disease? Prof John McBride James Cook University

dengue virus DENV DENV-1 DENV-2 DENV-3 DENV-4 NS1 Non-structural protein 1 NS1 DENV antibody-dependent enhancement ADE DENV

Public Health Image Library. CDC/ Cynthia Goldsmith. Image #

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

Categorisation of Dengue based on duration of fever and serological markers in a tertiary care hospital

Dengue Virus Disease: Current Updates on the use of Carica Papaya Leaf Extract as a Potential Herbal Medicine

Patterns of Gall Bladder Wall Thickening in Dengue Fever: A Mirror of the Severity of Disease

Dengue fever is the most commonly

Dengue Stephen J. Thomas, MD Director, Viral Diseases Branch Walter Reed Army Institute of Research (WRAIR) 14 AUG 2012

Yellow fever. Key facts

Evaluation of thrombocytopenia in dengue infection along with seasonal variation

Haemogram profile of dengue fever in adults during 19 September 12 November 2008: A study of 40 cases from Delhi

Sero-Prevalence of Dengue Infection by Rapid Immunochromatographic Assay from Tertiary Care Medical College Hospital in Coimbatore, India

INTRODUCTION. Dengue is one of the ten leading. Globally 20 million cases/yr. 24,000 deaths/yr. It is important to know the typical and atypical

JMSCR Vol 05 Issue 02 Page February 2017

A Study of platelet count with respect to Severity in the patients of Dengue at tertiary health care centre

Prevalence and risk factors of dengue vector infestation in schools at Dindigul, Tamil Nadu, India

Zika Virus. Centers for Disease Control and Prevention

Study of Correlation Between Platelet Count and Serological Markers of Dengue Infection with Importance of NS1 Antigen in Western Region of India

Zika Virus. Lee Green Vector-Borne Epidemiologist Indiana State Department of Health. April 13, 2016

A Study of Clinical Spectrum of Dengue Fever in A Tertiary Care

Dengue IgG/IgM/NS1 Combo Rapid Test Device

UNIVERSITI TEKNOLOGI MARA COPY NUMBER VARIATION OF FCGR3B GENE AMONG SEVERE DENGUE PATIENT IN MALAYSIA

Guidance for Investigation and Management of Zika Virus Infection

Global Perspectives on Dengue Research

Zika. Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas

Focus. International #57. Dengue Fever, Chikungunya and the Zika Virus. Chikungunya

A. Study Purpose and Rationale

Circulating levels of tumour necrosis factor-α & interferon-γ in patients with dengue & dengue haemorrhagic fever during an outbreak

CASE IN... Acute Infectious Diseases. in the Returning Traveller. James Case. Acute Infectious Diseases

Dengue hemorrhagic fever outbreak in children in Port Sudan

Fact sheet. Yellow fever

Skin and joint manifestations of

University of Veterinary and Animal Sciences, Bikaner), V.P.O. Bajor, Dist. Sikar, Rajasthan, India

SERUM FERRITIN LEVELS IN CHILDREN WITH DENGUE INFECTION

New epidemiological perspectives coming from dengue vaccine clinical trials. João Bosco Siqueira Jr Federal University of Goias - Brazil

ELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand

Dengue Virus-Danger from Deadly Little Dragon

ORIGINAL ARTICLE. A STUDY ON CLINICAL, LABORATORY PROFILE AND OUTCOME OF DENGUE FEVER Vanamali D.R 1, L. Venugopal 2, P. Yeshwanth 3, Dilip Rampure 4

Don't consume poor quality nilavembu powder, say siddha doctors

Dengue & Chikungunya In Asia Strategies for Testing

ZIKA VIRUS. Epic and aspects of management

Serological and haematological profile for early diagnosis of dengue infection in tertiary care hospital

Clinical and Laboratory Abnormalities due to Dengue in Hospitalized Children in Mumbai in 2004

Report of Four Volunteers with Primary, Secondary and Tertiary Dengue Infections during a Prospective Cohort Study

KILLER BITES: Mosquito-Borne Viruses Jon Mark Hirshon, MD, MPH, PhD

DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

University Journal of Pre and Para Clinical Sciences

CHIKUNGUNYA VIRUS INFECTION. Cesar Ponce S. Medical Microbiologist and Parasitologist. Epidemiologist ADC Medical Microbiology Department Director

Factsheet about Chikungunya

An Introduction to Dengue, Zika and Chikungunya Viruses

Dengue Update. Actualització sobre dengue

West Nile Virus. By Frank Riusech

What s Lurking out there??????

PRESENCE OF BOTH DENGUE SPECIFIC NS1 ANTIGEN AND IMMUNOGLOBULIN M ANTIBODY IN CONFIRMED DENGUE PATIENTS IN KOLKATA

Zika virus: laboratory diagnosis

Evaluation of NS1 Antigen Detection as Point of Care Test against Other Dengue Markers

Dengue: a trilogy of people, mosquitoes and the virus. Current epidemiology and pathogenesis in (non-)endemic settings Thai, K.T.D.

Dengue Vaccine Butantan Institute. DCVMN, Bangkok, 2015

Study of Clinical Profile of Dengue Fever: An Institutional Based Prospective Study

Haematological profile of dengue fever

Sero-Prevalence of Dengue in Tertiary Care Hospital in Delhi

Epidemiology and entomology of the Zika virus outbreak

SEROPOSITIVITY OF DENGUE VIRUS AND COMPARISON OF DENGUE IGM RAPID CARD SEROREACTIVE TEST WITH DENGUE

RESEARCH ARTICLE STUDY OF LIVER PROFILE IN DENGUE FEVER. Surendra H S*, Adarsh E, Hema.D, Varshini.P, Sirajudheen.P, Sherin Naseer

for determining dengue severity in Thai patients

ZIKA VIRUS. John J. Russell MD May 27, 2016

Dengue and Yellow Fever: the Anatomy of Decline and Emergence Duane J Gubler

Emerging TTIs How Singapore secure its blood supply

Olarn Prommalikit 1, Woraman Waidab 2, Kanya Suphapeetiporn 3 and Usa Thisyakorn 3

Transcription:

A Review on the Potential Therapeutic Profile of Carica papaya Leaf Extract in the Management of Dengue Fever - DR. PRADEEP B. E. POST GRADUATE DEPARTMENT OF PHARMACOLOGY, J.J.M.MEDICAL COLLEGE, DAVANGERE

INTRODUCTION Acute viral infection Dengue viruses (DV): genus Flavivirus, family Flaviviridae Positive stranded encapsulated RNA virus 3 structural protein genes: C, M, E 7 NS protein genes

Aedes aegypti mosquito transmission 1997 WHO classification of Dengue infection - Undifferentiated Fever - Dengue Fever (DF) and - Dengue Haemorrhagic Fever (DHF) 2009 WHO classification, - Uncomplicated - Severe

CLINICAL PRESENTATION Four main characteristic manifestations - Continuous high fever lasting 2-7 days; - Haemorrhagic tendency; - Thrombocytopenia (platelet count <100x109/L); and - Evidence of plasma leakage Incubation period: 3 to 14 days

After the incubation period, the illness begins abruptly Patients with moderate to severe disease, 3 phases - Febrile, - Critical and - Recovery Individual risk factors: secondary infection, age (young children), ethnicity and possibly chronic diseases Associated problems

Diagnosis Typically made clinically A probable diagnosis is based on the findings of fever plus any 2 of the characteristic features The earliest change detectable on laboratory investigations Peripheral vascular collapse in children Warning signs are an important aspect for early detection

Laboratory tests Diagnosis confirmed by microbiological laboratory testing - Virus isolation in cell cultures - Nucleic acid detection by PCR - Viral antigen detection (such as for NS1) or - Specific antibodies (serology) All tests may be negative in the early stages of the disease PCR and viral antigen detection are more accurate in the first seven days

Problem Statement Risk population: Over 2.5 billion people over 40% of the world s population WHO estimation, 50 100 million dengue infections and half a million DHF worldwide every year Average case fatality rate 5 % Endemic in over 125 countries The exact extent of the problem not known

Currently available treatment modalities Treatment depends on the symptoms & severity IV fluids- titrated Blood transfusion initiated early in patients presenting with unstable vital signs Packed red blood cells or whole blood recommended Thrombocytopenia not addressed till it gets lowered down to levels less than 20000 /μl Reduction of mortality due to DHF from 20% to less than 1% Corticosteroid

TPO agonists and mimetics like Eltrombopag and Romiplastim Dengue vaccine under trial Alternatively other options need to be explored Considerations for alternate therapies Traditional medicine

Carica papaya (CP) Genus Carica of the plant family Caricaceae Cosmopolitan in distribution Leaves of Papaw are rich in anthraquinone and alkaloids like carpaine, a glucoside named carposide, flavonols and vitamins C and E TJ O Hare and DJ Williams - Papaya As A Medicinal Plant anthelmintic activity, wound healing, antifertility properties, antifungal activity, antimalarial activity, antimicrobial activity, antiviral activity (dengue fever), anticancer and chemoprotection, anti-amoebic activity, diabetes and antihypertension

Literature search: consistent results *NADEEM SHEIKH, NEELAM YOUNAS & TASLEEM AKHTAR on Effect of Carica papaya leaf formulation on Haematology and Serology of normal rat illustrated an exact mechanism of Thrombocyte formation Consumption for longer period: hepatotoxicity and risk for cardiovascular disease Probable action of Vitamin C In a clinical trials, 1100 mg TID of Carica Papaya leaf extract tablet (Caripill) for 5 days significant increase in platelet count

Sathasivam et al. (2009) mice Ahmad et al. (2011), Hettige S. (2008), Yunita F (2012) and Soobitha Subenthiran (2013) clinical trials NADEEM SHEIKH et al. Effect of Carica papaya leaf formulation on Haematology and Serology of normal rat - mean platelet count, MCH, MCV Identification of Secondary Metabolites Present in Carica Papaya L. Leaf Extract Found in Northern India by HPTLC & Other Test Procedures, its Significance and Role in Curing Dengue/DHF Disease by Dinesh Kumar et al. - physico-chemical and phytochemical evaluation

TLC fingerprinting profile of different extracts Secondary metabolites Bioactive components separated from the co extractives Secondary metabolites Flavonoids like quercetin, alkaloids like piperine, glycosides, saponins, tannins, terpenoids like triterpenoids, phytosterols and phenolics None any single ingredient/constituent or factor found responsible

Significance Better & viable option in fever associated with thrombocytopenia Palatable and appropriately formulated Fewer side effects Decreases the cost of hospitalization Cost effective More affordable and accessible Averting the mortalities

International Anti dengue day - June 15 th Intention to meet the achievable goals

CONCLUSION Serious public health problem worldwide Validation of traditional claims Discrepancy regarding its safety profile Cost effective - positive influence on the national economy Need for further studies on a large scale Considerations for nutraceutical and its potential as pharmaceutical

References Nivedita Gupta et al. Dengue in India; Centenary Review Article; Indian J Med Res. 136, p 373-390, September 2012. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control (PDF) (2nd ed.). Geneva: World Health Organization. pp. 12 23. ISBN 92-4-154500-3. WHO (2009), pp. 10 11. WHO. 2. Dengue: Guidelines for diagnosis, treatment, prevention, and control in sub-saharan Africa and 13 countries in South America. Geneva: World Health Organization; 2009, 2012.

Esler D. Dengue - Clinical and public health ramifications. Aust Fam Physician. 38:876 879, 2009. (PubMed). Halstead S. B. The pathogenesis of dengue: Molecular Epidemiology in Infections Disease. Am J Epidemiol. 114(5): 632-648, 1981. Ferreira G.L. Global dengue epidemiology trends. Rev Inst Med Trop Sao Paulo.54 (Suppl 18):S5 6, 2012. (PubMed) Selisko B, Dutartre H, Guillemot JC. Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA dependent RNA polymerases. Virology 2006; 351(1): 145-148. "Re: Papaya leaves for speedy rise of platelet count in Dengue. BMJ. Retrieved 2013-06-15.

Good Health Needs Good Care